Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Cancer Letters|July 13, 2021
Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axisLisha Li, Dongfeng Song, Ling Qi, et al.Journal of Colloid and Interface Science|June 13, 2022
Buffet-style Cu(II) for enhance disulfiram-based cancer therapyLiping Zhao, Xiaoxia Wang, Han Lou, et al.Thoracic Cancer|July 4, 2023
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancerYue Chai, Jiaxuan Liu, Mingxia Jiang, et al.Frontiers in Neurology|May 5, 2022
Mechanical Thrombectomy for Acute Ischemic Stroke in Patients With Cardiac Myxoma: A Case Series and Pooled AnalysisJie Rao, Zi Tao, Qiongqiong Bao, et al.Breast Cancer (Dove Medical Press)|August 27, 2025
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective StudyShihan Zhou, Mingxia Jiang, Jiaxuan Liu, et al.Therapeutic Advances in Medical Oncology|September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center studyMingxia Jiang, Jiaxuan Liu, Maiyue He, et al.BMC Cancer|October 18, 2024
Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II studyJiaxuan Liu, Maiyue He, Mingxia Jiang, et al.Therapeutic Advances in Medical Oncology|October 16, 2023
Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter studyMingxia Jiang, Bin Shao, Donggui Wan, et al.International Journal of Cancer|September 7, 2023
Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer: A prospective cohort study with propensity-matched analysisJiaxuan Liu, Maiyue He, Kaiping Ou, et al.Vaccine|August 31, 2024
Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59Xin Chi, Feng Han, Yanan Jiang, et al.Pageof 6